Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC

BackgroundHLRCC-associated RCC (hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinoma) caused by germline mutations of the fumarate hydratase (FH) gene is a rare autosomal dominant genetic renal cancer. At present, there are no reports of bilateral kidneys with HLRCC-associ...

Full description

Bibliographic Details
Main Authors: Kunhan Dai, Wencheng Jiang, Siyu Chen, Shengjun Luo, Siwei Ding, Delin Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.932996/full
_version_ 1811251419548745728
author Kunhan Dai
Wencheng Jiang
Siyu Chen
Shengjun Luo
Siwei Ding
Delin Wang
author_facet Kunhan Dai
Wencheng Jiang
Siyu Chen
Shengjun Luo
Siwei Ding
Delin Wang
author_sort Kunhan Dai
collection DOAJ
description BackgroundHLRCC-associated RCC (hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinoma) caused by germline mutations of the fumarate hydratase (FH) gene is a rare autosomal dominant genetic renal cancer. At present, there are no reports of bilateral kidneys with HLRCC-associated RCC, let alone safe pregnancy after twice partial nephrectomy for bilateral kidney HLRCC-associated RCC.Case presentationWe report a 25-year-old woman with bilateral renal tumors detected by ultrasound screening during a routine checkup. CT revealed a soft tissue mass in the parenchyma of the left kidney and a nodular soft tissue mass in the lower pole of the right kidney. She underwent robot-assisted laparoscopic left partial nephrectomy and underwent laparoscopic right partial nephrectomy 3 months after the first surgery. Heterozygous mutation in the FH gene on the patient’s tumor tissue was detected by genetic testing. Combined with the patient’s medical history, microstructure and immunohistochemical staining of tumor tissue, and genetic test results, the pathological reports after two operations concluded HLRCC-associated RCC. Then, she was injected with interferon and nivolumab as a preventative treatment against tumor recurrence. Up to 38 months after surgery, having given birth to a baby, till now there was no tumor progression.ConclusionsThis is a clinically significant case, as it provides a reference for pregnancy in patients undergoing partial nephrectomy for bilateral kidneys with HLRCC-associated RCC and may indicate an effective approach to preventing tumor recurrence by nivolumab in patients with HLRCC-associated RCC.
first_indexed 2024-04-12T16:20:07Z
format Article
id doaj.art-8e722c7e1fac4d2d9fdafbe62dc3acd0
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T16:20:07Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-8e722c7e1fac4d2d9fdafbe62dc3acd02022-12-22T03:25:36ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-10-011210.3389/fonc.2022.932996932996Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCCKunhan DaiWencheng JiangSiyu ChenShengjun LuoSiwei DingDelin WangBackgroundHLRCC-associated RCC (hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinoma) caused by germline mutations of the fumarate hydratase (FH) gene is a rare autosomal dominant genetic renal cancer. At present, there are no reports of bilateral kidneys with HLRCC-associated RCC, let alone safe pregnancy after twice partial nephrectomy for bilateral kidney HLRCC-associated RCC.Case presentationWe report a 25-year-old woman with bilateral renal tumors detected by ultrasound screening during a routine checkup. CT revealed a soft tissue mass in the parenchyma of the left kidney and a nodular soft tissue mass in the lower pole of the right kidney. She underwent robot-assisted laparoscopic left partial nephrectomy and underwent laparoscopic right partial nephrectomy 3 months after the first surgery. Heterozygous mutation in the FH gene on the patient’s tumor tissue was detected by genetic testing. Combined with the patient’s medical history, microstructure and immunohistochemical staining of tumor tissue, and genetic test results, the pathological reports after two operations concluded HLRCC-associated RCC. Then, she was injected with interferon and nivolumab as a preventative treatment against tumor recurrence. Up to 38 months after surgery, having given birth to a baby, till now there was no tumor progression.ConclusionsThis is a clinically significant case, as it provides a reference for pregnancy in patients undergoing partial nephrectomy for bilateral kidneys with HLRCC-associated RCC and may indicate an effective approach to preventing tumor recurrence by nivolumab in patients with HLRCC-associated RCC.https://www.frontiersin.org/articles/10.3389/fonc.2022.932996/fullpregnancyhereditary carcinomarenal cell carcinomapartial nephrectomyFH
spellingShingle Kunhan Dai
Wencheng Jiang
Siyu Chen
Shengjun Luo
Siwei Ding
Delin Wang
Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC
Frontiers in Oncology
pregnancy
hereditary carcinoma
renal cell carcinoma
partial nephrectomy
FH
title Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC
title_full Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC
title_fullStr Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC
title_full_unstemmed Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC
title_short Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC
title_sort case report going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with hlrcc associated rcc
topic pregnancy
hereditary carcinoma
renal cell carcinoma
partial nephrectomy
FH
url https://www.frontiersin.org/articles/10.3389/fonc.2022.932996/full
work_keys_str_mv AT kunhandai casereportgoingthroughpregnancysafelyaftertwicepartialnephrectomyforbilateralkidneyswithhlrccassociatedrcc
AT wenchengjiang casereportgoingthroughpregnancysafelyaftertwicepartialnephrectomyforbilateralkidneyswithhlrccassociatedrcc
AT siyuchen casereportgoingthroughpregnancysafelyaftertwicepartialnephrectomyforbilateralkidneyswithhlrccassociatedrcc
AT shengjunluo casereportgoingthroughpregnancysafelyaftertwicepartialnephrectomyforbilateralkidneyswithhlrccassociatedrcc
AT siweiding casereportgoingthroughpregnancysafelyaftertwicepartialnephrectomyforbilateralkidneyswithhlrccassociatedrcc
AT delinwang casereportgoingthroughpregnancysafelyaftertwicepartialnephrectomyforbilateralkidneyswithhlrccassociatedrcc